Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Safe Supply Announces Proposed Acquisition of European Medical Testing Subsidiary (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Resverlogix Corp
T.RVX
Alternate Symbol(s):
RVXCF
Healthcare
Biotechnology
Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the...
treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSX:RVX)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
81
82
83
84
85
86
87
88
89
Next
(14)
•••
narmac
X
View Profile
View Bullboard History
Post by
narmac
on Aug 10, 2020 9:51am
7 other molecules sitting in limbo!
,,I am trying to figure out for what reason these molecules sit in limbo???....is it greed by the team thinking each molecule is a blockbuster.....or is it just poor business sense to not sell one or
...more
(14)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Aug 05, 2020 11:57am
RE:RE:RE:RE:COVID-19 Preclinical Work Continues
general,,,my sentiments exactly,,,if DMcC cant get a juicy deal signed sealed and delivered with the FDAs break thru designation then his back history legacy amounts to just prolonging this agony and
...more
(15)
•••
general360
X
View Profile
View Bullboard History
Comment by
general360
on Aug 05, 2020 10:28am
RE:RE:RE:COVID-19 Preclinical Work Continues
wow this just keeps getting better and better! PI running for the exits this morning, dumped at the open, i saw that too...I consider them a boutique investing firm, not your average joe....when
...more
(14)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Aug 05, 2020 9:35am
RE:RE:COVID-19 Preclinical Work Continues
,,yep,,the investing world is wiping their a$$ with the publication,,,,95000 shares sold into the bid right off the get go thbis am!! Awesome DMcC you are doping an incredible job for somebody,,it
...more
(14)
•••
narmac
X
View Profile
View Bullboard History
Comment by
narmac
on Aug 04, 2020 3:40pm
RE:COVID-19 Preclinical Work Continues
huuuummmm,,,,,the press release this morning about the publication,,,,,,it must be thought of as a$$ paper to wipe your backside with,,,, ,,,seems to have made the share price support even weaker!! I
...more
(6)
•••
fishtail
X
View Profile
View Bullboard History
Post by
fishtail
on Aug 04, 2020 10:35am
Houses last 4 weeks led by anon
House Positions for C:RVX from 20200706 to 20200804 House Bought $Val Ave Sold $Val Ave Net $Net 1
...more
(92)
•••
G1945V
X
View Profile
View Bullboard History
Comment by
G1945V
on Aug 04, 2020 8:22am
RE:COVID-19 Preclinical Work Continues
RVX WEB Page: https://www.resverlogix.com/investors/news.html?article=671 G1945V
(92)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on Aug 04, 2020 8:19am
COVID-19 Preclinical Work Continues
Resverlogix Announces Publication on Apabetalone in Cardiovascular Therapeutics: CALGARY, Alberta, Aug. 04, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company
...more
(120)
•••
ENEMENEMYNEMO
X
View Profile
View Bullboard History
Comment by
ENEMENEMYNEMO
on Jul 31, 2020 8:13pm
RE:Epigenetic Therapeutic Target Virtual Summit Presentatations
Watch for it....Covid Trial.... phase 2...accelerated
(6)
•••
BearDownAZ
X
View Profile
View Bullboard History
Post by
BearDownAZ
on Jul 29, 2020 10:30am
Epigenetic Therapeutic Target Virtual Summit Presentatations
Resverlogix and Zenith both presented yesterday at Epigenetic Therapeutic Target Virtual Summit https://www.resverlogix.com/upload/media_element/215/a92c88143fe9/2020-07-28-epigenetic
...more
(92)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on Jul 29, 2020 9:30am
Merck to Collaborate with UCSF and Zenith
Merck to Collaborate with UCSF and Zenith in a New Phase 2 mCRPC Clinical Trial CALGARY, Alberta, July 29, 2020 (GLOBE NEWSWIRE) -- Zenith Epigenetics Ltd. (“Zenith” or the “Company”) announced
...more
(92)
•••
G1945V
X
View Profile
View Bullboard History
Post by
G1945V
on Jul 28, 2020 6:07pm
Resverlogix Announces Extension of its Filing
Resverlogix Announces Extension of its Filing Calendar Based on Continuous Disclosure Exemption CALGARY, Alberta, July 28, 2020 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the
...more
Prev
...
81
82
83
84
85
86
87
88
89
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Topgolf Takes Fortnite by Storm – Gamers Can Now Swing, Score, and Win Big in the Virtual World